4-[6-imino-3-(4-methoxyphenyl)pyridazin-1-yl]butanoic acid
-
![4-[6-imino-3-(4-methoxyphenyl)pyridazin-1-yl]butanoic acid structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220811/3a8f7cb0e43c483f9746250a6606d908.png "4-[6-imino-3-(4-methoxyphenyl)pyridazin-1-yl]butanoic acid")
4-[6-imino-3-(4-methoxyphenyl)pyridazin-1-yl]butanoic acid
structure -
-
CAS No:
105538-73-6
-
Formula:
C15H17N3O3
-
Chemical Name:
4-[6-imino-3-(4-methoxyphenyl)pyridazin-1-yl]butanoic acid
-
Synonyms:
6-amino-5-methyl-3-(4-methoxyphenyl)-1-pyridaziniumbutyric acid, bromide;gabazine;SR 95531;SR-95531;Gabazine;Gabazine free base;105538-73-6;SR95531;CHEBI:34968;UNII-L45297DIU1;4-(6-imino-3-(4-methoxyphenyl)pyridazin-1(6H)-yl)butanoic acid;Tocris-1262;Prestwick0_000443;Prestwick1_000443;Prestwick2_000443;C13796;CHEMBL32503;L45297DIU1;4-[6-imino-3-(4-methoxyphenyl)pyridazin-1-yl]butanoic acid;6-imino-3-(4-methoxyphenyl)-1(6h)-pyridazinebutanoic acid;1(6H)-Pyridazinebutanoic acid, 6-imino-3-(4-methoxyphenyl)-;1,6-Dihydro-6-imino-3-(4-methoxyphenyl)-1-pyridazinebutanoic acid;4-(6-Imino-3-(4-methoxyphenyl)pyridazin-1-yl)butanoic acid;4-[6-imino-3-(4-methoxyphenyl)-1,6-dihydropyridazin-1-yl]butanoic acid;[3H]gabazine;2-(3-Carboxypropyl)-3-amino-6-(4-methoxyphenyl)pyridazinium;J331.170H;Biomol-NT_000259;SPBio_002425;BPBio1_000771;GTPL4083;GTPL4197;SCHEMBL5529434;DTXSID20276043;4-(6-Imino-3-(4-methoxyphenyl)-1(6H)-pyridazinyl)butanoic acid;BCP33110;ZINC2559949;BDBM50001572;PDSP1_001604;PDSP2_001588;ZINC02559949;AKOS030254307;NCGC00025088-01;NCGC00025088-02;NCGC00025088-03;FT-0668923;G-215;J-001443;BRD-K79905821-001-01-6;Q27894364;SR95531; SR 95531; SR-95531;4-[6-imino-3-(4-methoxyphenyl)pyridazin-1-yl]butanoic acid.;4-[6-Imino-3-(4-methoxy-phenyl)-6H-pyridazin-1-yl]-butyric acid;(gabazine)4-[6-Imino-3-(4-methoxy-phenyl)-6H-pyridazin-1-yl]-butyric acid;4-[6-Imino-3-(4-methoxy-phenyl)-6H-pyridazin-1-yl]-butyric acid (gabazine or SR-95331);4-[6-Imino-3-(4-methoxy-phenyl)-6H-pyridazin-1-yl]-butyric acid(Gabazine)
-
CAS No:
4-[6-imino-3-(4-methoxyphenyl)pyridazin-1-yl]butanoic acid Basic Attributes
287.31 g/mol
287.12699141 g/mol
L45297DIU1
DTXSID20276043
Drug Information
Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS. (See all compounds classified as GABA Antagonists.)
6-amino-5-methyl-3-(4-methoxyphenyl)-1-pyridaziniumbutyric acid, bromide
Computed Properties
Molecular Weight:287.31
XLogP3:1.4
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:6
Exact Mass:287.12699141
Monoisotopic Mass:287.12699141
Topological Polar Surface Area:86
Heavy Atom Count:21
Complexity:451
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
3,5-DIBROMO-2-[[[(3,5-DINITROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
535965-38-9
-
3,5-DIBROMO-2-[[[[(2-CHLOROPHENOXY)ACETYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
532386-89-3
-
3,5-DIBROMO-2-[[[(4-METHYL-3-NITROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
532943-48-9
-
3,5-DIBROMO-2-[[[[3-(2-FURANYL)-1-OXO-2-PROPENYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Formula
586392-09-8
-
3,5-DIBROMO-2-[[[[(2-METHYLPHENOXY)ACETYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Formula
531548-30-8
-
2-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoic acid Formula
333340-54-8
-
3,5-DIBROMO-2-[[[[3-(PHENOXYMETHYL)BENZOYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Structure
586393-79-5
-
3,5-DIBROMO-2-[[[(4-CHLOROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Structure
531530-32-2
-
What is 2-Cyclopentyl-3-(2,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-oxo-4-isoquinolinecarboxylic acid
400073-92-9
-
What is 9-Octadecenoic acid (9Z)-, compd. with N,N-dimethylcyclohexanamine (1:1)
65122-23-8
Request for Quotation